These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3469466

  • 21. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [Abstract] [Full Text] [Related]

  • 22. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ, Jenkinson EJ, Owen JJ.
    Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
    [Abstract] [Full Text] [Related]

  • 23. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C, Debré P, Leclerc JC.
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [Abstract] [Full Text] [Related]

  • 24. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N, Boone CW, Holden HT, Herberman RB.
    Int J Cancer; 1978 Jan 15; 21(1):78-84. PubMed ID: 203543
    [Abstract] [Full Text] [Related]

  • 25. Defective cytotoxic T-cell generation in Moloney murine sarcoma virus-infected A/Sn mice.
    Becker S, Klein E.
    J Natl Cancer Inst; 1980 Oct 15; 65(4):811-6. PubMed ID: 6968372
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.
    Glaser M, Kirchner H, Holden HT, Herberman RB.
    J Natl Cancer Inst; 1976 Apr 15; 56(4):865-7. PubMed ID: 1255803
    [Abstract] [Full Text] [Related]

  • 27. Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area.
    Rosato A, Zambon A, Macino B, Mandruzzato S, Bronte V, Milan G, Zanovello P, Collavo D.
    Int J Cancer; 1996 Mar 15; 65(6):847-51. PubMed ID: 8631602
    [Abstract] [Full Text] [Related]

  • 28. Monoclonal antibody detects a common surface antigen on two independently established murine Moloney sarcoma virus non-producer transformants.
    Weiland E, Thiel HJ.
    J Gen Virol; 1985 Sep 15; 66 ( Pt 9)():1863-72. PubMed ID: 2993478
    [Abstract] [Full Text] [Related]

  • 29. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R, Duffy T.
    J Immunol; 1985 Jun 15; 134(6):4255-60. PubMed ID: 3872913
    [Abstract] [Full Text] [Related]

  • 30. The in vivo role of leukocyte function-associated antigen-1 in cytotoxic cell activity against tumors induced by Moloney-murine sarcoma/leukemia retroviral complex.
    Rosato A, Bronte V, Pollis F, Mandruzzato S, Zambon A, Zanovello P, Collavo D.
    Leukemia; 1992 Jun 15; 6 Suppl 3():166S-167S. PubMed ID: 1602816
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: no requirement for exogenous C5.
    Fuson EW, Walia AS, Cox BA, Lamon EW.
    Clin Immunol Immunopathol; 1979 Sep 15; 14(1):35-46. PubMed ID: 477041
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM, Prehn RT.
    J Natl Cancer Inst; 1978 Nov 15; 61(5):1323-7. PubMed ID: 213613
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr 15; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 39. Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.
    Kodama K, Ghanta VK, Hiramoto NS, Hiramoto RN.
    J Biol Response Mod; 1989 Aug 15; 8(4):385-96. PubMed ID: 2754437
    [Abstract] [Full Text] [Related]

  • 40. Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection.
    Collavo D, Colombatti A, Biasi G, Chieco-Bianchi L, Davies AJ.
    J Natl Cancer Inst; 1976 Mar 15; 56(3):603-8. PubMed ID: 176399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.